Maxim Group Significantly Raises Achillion's PT, Shares Soar +15%

By: via Benzinga
Maxim Group analyst Jason Kolbert raised the price target on Buy rated Achillion Pharmaceuticals (NASDAQ: ACHN) from $6.00 to $22.00. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.